REFRACTORY T LYMPHOBLASTIC LYMPHOMA

Clinical trials for REFRACTORY T LYMPHOBLASTIC LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY T LYMPHOBLASTIC LYMPHOMA trials appear

Sign up with your email to follow new studies for REFRACTORY T LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug duo aims to knock out stubborn leukemia

Disease control Ongoing

This study is testing a combination of two drugs, venetoclax and vincristine, for adults with a fast-growing blood cancer called acute lymphoblastic leukemia (ALL) that has come back or hasn't responded to previous treatments. The goal is to see if using these drugs together is s…

Matched conditions: REFRACTORY T LYMPHOBLASTIC LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

REFRACTORY T LYMPHOBLASTIC LYMPHOMA

Get alerted when new REFRACTORY T LYMPHOBLASTIC LYMPHOMA trials appear

New drug duo aims to knock out stubborn leukemia